New Targets for End-Stage Chronic Kidney Disease Therapy

1. Lozano, R. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–128.10.1016/S0140-6736(12)61728-0Search in Google Scholar

2. Huby AC, Rastaldi MP, Caron K, Smithies O, Dussaule JC, Chatziantoniou C. Restoration of podocyte structure and improvement of chronic renal disease in transgenic mice overexpressing renin. PLoS One. 2009;21:e6721.10.1371/journal.pone.0006721Search in Google Scholar

3. Kavvadas P, Weis L, Abed AB, Feldman DL, Dussaule JC, Chatziantoniou C. Renin inhibition reverses renal disease in transgenic mice by shifting the balance between profibrotic and antifibrotic agents. Hypertension. 2013;61:901-7.10.1161/HYPERTENSIONAHA.111.00639Search in Google Scholar

4. Chatziantoniou C, Dussaule JC. Is kidney injury a reversible process? CurrOpinNephrolHypertens. 2008;17:76-81.Search in Google Scholar

5. Mauer M, Zinman B, Gardiner R, et al. Renal and retinal effects of enalapril and losartan in type 1 diabetes. N Engl J Med. 2009;361:40-51.10.1056/NEJMoa0808400Search in Google Scholar

6. Kruzynska-Frejtag A, Machnicki M, Rogers R, Markwald RR, Conway SJ. Periostin (an osteoblast-specific factor) is expressed within the embryonic mouse heart during valve formation. Mech Dev. 2001;103:183-8.10.1016/S0925-4773(01)00356-2Search in Google Scholar

7. Norris RA, Kern CB, Wessels A, et al. Identification and detection of the periostin gene in cardiac development. AnatRec A Discov Mol CellEvolBiol. 2004;281:1227-33.10.1002/ar.a.2013515532025Search in Google Scholar

8. Corren J, Lemanske RF, Hanania NA, et al. Lebrikizumab treatment in adults with asthma. N Engl J Med. 2011;365:1088-98.10.1056/NEJMoa110646921812663Search in Google Scholar

9. Naik PK, Bozyk PD, Bentley JK, et al. Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2012;303:L1046-56.10.1152/ajplung.00139.2012353258323043074Search in Google Scholar

10. Guerrot D, Dussaule JC, Mael-Ainin M, et al. Identification of periostin as a critical marker of progression/reversal of hypertensive nephropathy. PLoS One. 2012;7:e3197410.1371/journal.pone.0031974329387422403621Search in Google Scholar

11. Sen K, Lindenmeyer MT, Gaspert A, et al. Periostin is induced in glomerular injury and expressed de novo in interstitial renal fibrosis. Am J Pathol. 2011;179:1756-67.10.1016/j.ajpath.2011.06.002318139221854746Search in Google Scholar

12. Mael-Ainin M, Abed A, Conway S, Dussaule JC, Chatziantoniou C. Inhibition of Periostin expression protects against the development of renal inflammation and fibrosis. J Am SocNephrol. 2014;25:1724-36.10.1681/ASN.2013060664411605624578131Search in Google Scholar

13. Satirapoj B, Wang Y, Chamberlin MP, et al. Periostin: novel tissue and urinary biomarker of progressive renal injury induces a coordinated mesenchymal phenotype in tubular cells. Nephrol Dial Transplant.2012;27:2702-11.10.1093/ndt/gfr670347154922167593Search in Google Scholar

14. Li L, Fan D, Wang C, et al. Angiotensin II increases periostin expression via Ras/p38 MAPK/CREB and ERK1/2/TGF-β1 pathways in cardiac fibroblasts. CardiovascRes. 2011;91:80-89.10.1093/cvr/cvr06721367774Search in Google Scholar

15. Uchida M, Shiraishi H, Ohta S, et al. Periostin, a matricellularprotein, plays a role in the induction of chemokines in pulmonaryfibrosis. Am J RespirCell Mol Biol. 2012;46:677-86.10.1165/rcmb.2011-0115OC430436722246863Search in Google Scholar

16. Curat C.A. and Vogel W.F., Discoidin domain receptor 1 controls growth and adhesion of mesangial cells. J Am Soc Nephrol. 2002;13:2648-2656.10.1097/01.ASN.0000032419.13208.0C12397034Search in Google Scholar

17. Flamant M, Placier S, Rodenas A, et al. Discoidin domain receptor 1 null mice are protected against hypertension-induced renal disease. J Am Soc Nephrol. 2006;17:3374-81.10.1681/ASN.200606067717093065Search in Google Scholar

18. Kerroch M, Guerrot D, Vandermeersch S, et al. Genetic inhibition of discoidin domain receptor 1 protects mice against crescentic glomerulonephritis. Faseb J. 2012;26:4079-91.10.1096/fj.11-19490222751008Search in Google Scholar

19. Guerrot D, Kerroch M, Placier S, et al. Discoidin domain receptor 1 is a major mediator of inflammation and fibrosis in obstructive nephropathy. Am J Pathol. 2011;179:83-91.10.1016/j.ajpath.2011.03.023312384321640971Search in Google Scholar

20. Gross O, Girgert R, Beirowski B, et al. Loss of collagen-receptor DDR1 delaysrenalfibrosis in hereditary type IV collagendisease. Matrix Biol.2010;29:346-56.10.1016/j.matbio.2010.03.00220307660Search in Google Scholar

21. Avivi-Green C, Singal M, Vogel WF. Discoidin domain receptor 1-deficient mice are resistant to bleomycin-induced lung fibrosis. Am J RespirCrit Care Med. 2006;174:420-27.10.1164/rccm.200603-333OC16690978Search in Google Scholar